Kyle Gowen

2.9k total citations
24 papers, 1.1k citations indexed

About

Kyle Gowen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Kyle Gowen has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Kyle Gowen's work include Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Colorectal Cancer Treatments and Studies (5 papers). Kyle Gowen is often cited by papers focused on Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Colorectal Cancer Treatments and Studies (5 papers). Kyle Gowen collaborates with scholars based in United States, Australia and Italy. Kyle Gowen's co-authors include Siraj M. Ali, Vincent A. Miller, Jeffrey S. Ross, Alexa B. Schrock, Garrett M. Frampton, David Fabrizio, Sai‐Hong Ignatius Ou, Philip J. Stephens, Samuel J. Klempner and James Sun and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Kyle Gowen

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kyle Gowen United States	14	712	465	354	294	255	24	1.1k
Hideyuki Abe Japan	20	416 0.6×	351 0.8×	213 0.6×	141 0.5×	294 1.2×	63	907
Angela N. Bartley United States	16	605 0.8×	388 0.8×	318 0.9×	322 1.1×	208 0.8×	27	1.1k
Patrick R. Benusiglio France	15	515 0.7×	413 0.9×	352 1.0×	263 0.9×	652 2.6×	38	1.3k
Seung Eun Lee South Korea	19	475 0.7×	545 1.2×	239 0.7×	177 0.6×	310 1.2×	46	1.0k
Joel Greenbowe United States	13	780 1.1×	531 1.1×	529 1.5×	258 0.9×	338 1.3×	20	1.1k
Kerry D. Lynch United States	6	285 0.4×	319 0.7×	233 0.7×	168 0.6×	352 1.4×	7	887
Julia Kitz Germany	22	564 0.8×	280 0.6×	296 0.8×	121 0.4×	426 1.7×	52	1.2k
Marie‐Paule Sablin France	18	499 0.7×	289 0.6×	354 1.0×	100 0.3×	410 1.6×	50	942
Bin Meng China	18	334 0.5×	186 0.4×	141 0.4×	151 0.5×	245 1.0×	62	814
Chikako Shimizu Japan	17	626 0.9×	166 0.4×	484 1.4×	205 0.7×	157 0.6×	53	975

Countries citing papers authored by Kyle Gowen

Since Specialization

Citations

This map shows the geographic impact of Kyle Gowen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Gowen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Gowen more than expected).

Fields of papers citing papers by Kyle Gowen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Gowen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Gowen. The network helps show where Kyle Gowen may publish in the future.

Co-authorship network of co-authors of Kyle Gowen

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Gowen. A scholar is included among the top collaborators of Kyle Gowen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Gowen. Kyle Gowen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Trabucco, Sally E., Kyle Gowen, Sophia L. Maund, et al.. (2019). A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability–High Cases in 67,000 Patient Samples. Journal of Molecular Diagnostics. 21(6). 1053–1066. 162 indexed citations

Gowen, Kyle, Travis Clark, Jeffrey P. Gregg, et al.. (2019). MSI-H testing via hybrid capture based NGS sequencing of liquid biopsy samples.. Journal of Clinical Oncology. 37(4_suppl). 504–504. 4 indexed citations

Fabrizio, David, Thomas J. George, Richard F. Dunne, et al.. (2018). Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition. Journal of Gastrointestinal Oncology. 9(4). 610–617. 195 indexed citations

Klempner, Samuel J., Kyle Gowen, Thomas K. Lee, et al.. (2018). Carving out another slice of the pie: Exceptional response to single agent imatinib in an asian female never-smoker with advanced NSCLC with a de-novo PDGFR-α N848 K mutation. Lung Cancer. 124. 86–89. 1 indexed citations

Gupta, Sumati, David C. Gaston, Marta E. Heilbrun, et al.. (2017). Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)–Deficient Carcinomas of the Urinary System. Clinical Genitourinary Cancer. 16(2). e373–e382. 5 indexed citations

Linehan, W. Marston, Viola W. Zhu, Satoshi Yoda, et al.. (2017). MA 07.07 Clinical Outcomes and ALK Resistance Mutations in ALK+ Non-Small Cell Lung Cancer According to EML4-ALK Variant. Journal of Thoracic Oncology. 12(11). S1828–S1828. 2 indexed citations

Allen, Allison, Siraj M. Ali, Kyle Gowen, Julia A. Elvin, & Tanja Pejović. (2017). A recurrent endometrial stromal sarcoma harbors the novel fusion JAZF1-BCORL1. Gynecologic Oncology Reports. 20. 51–53. 36 indexed citations

Ou, Sai‐Hong Ignatius, Alexa B. Schrock, Kyle Gowen, et al.. (2017). Association of ALK resistance mutations by EML4-ALK variant (v3 vs. non-v3) in ALK+ non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 35(15_suppl). 9010–9010. 14 indexed citations

Weinberg, Benjamin A., Kyle Gowen, Thomas K. Lee, et al.. (2017). Comprehensive Genomic Profiling Aids in Distinguishing Metastatic Recurrence from Second Primary Cancers. The Oncologist. 22(2). 152–157. 11 indexed citations

10.

Yakirevich, Evgeny, Murray B. Resnick, Shamlal Mangray, et al.. (2016). Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target. Clinical Cancer Research. 22(15). 3831–3840. 88 indexed citations

11.

Zhu, Viola W., Daya Upadhyay, Alexa B. Schrock, et al.. (2016). TPD52L1-ROS1, a new ROS1 fusion variant in lung adenosquamous cell carcinoma identified by comprehensive genomic profiling. Lung Cancer. 97. 48–50. 33 indexed citations

12.

Okimoto, Ross A., Frank Breitenbuecher, Victor Olivas, et al.. (2016). Inactivation of Capicua drives cancer metastasis. Nature Genetics. 49(1). 87–96. 117 indexed citations

13.

Subbiah, Vivek, Oliver Holmes, Kyle Gowen, et al.. (2016). Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion. Oncology. 91(6). 348–353. 28 indexed citations

14.

Frampton, Garrett M., Alexa B. Schrock, Zachary R. Chalmers, et al.. (2016). Comprehensive genomic profiling (CGP) to assess mutational load in gastric and esophageal adenocarcinomas: Implications for immunotherapies.. Journal of Clinical Oncology. 34(4_suppl). 66–66. 2 indexed citations

15.

Hall, Michael J., Kyle Gowen, Eric M. Sanford, et al.. (2016). Evaluation of microsatellite instability (MSI) status in gastrointestinal (GI) tumor samples tested with comprehensive genomic profiling (CGP).. Journal of Clinical Oncology. 34(4_suppl). 528–528. 10 indexed citations

16.

George, Thomas J., Garrett M. Frampton, James Sun, et al.. (2016). Tumor mutational burden as a potential biomarker for PD1/PD-L1 therapy in colorectal cancer.. Journal of Clinical Oncology. 34(15_suppl). 3587–3587. 25 indexed citations

17.

Klempner, Samuel J., Thomas K. Lee, Mark G. Erlander, et al.. (2016). BRAF V600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF–MEK Combination Therapy. Cancer Discovery. 6(6). 594–600. 74 indexed citations

18.

Santin, Alessandro D., Kathleen N. Moore, Camille C. Gunderson, et al.. (2016). Immunotherapy (IO) versus targeted therapy triage in endometrial adenocarcinoma (EA) by concurrent assessment of tumor mutation burden (TMB), microsatellite instability (MSI) status, and targetable genomic alterations (GA).. Journal of Clinical Oncology. 34(15_suppl). 5591–5591. 2 indexed citations

19.

Klempner, Samuel J., Lyudmila Bazhenova, Fadi S. Braiteh, et al.. (2015). Emergence of RET rearrangement co-existing with activated EGFR mutation in EGFR -mutated NSCLC patients who had progressed on first- or second-generation EGFR TKI. Lung Cancer. 89(3). 357–359. 72 indexed citations

20.

Klempner, Samuel J., Rodolfo Bordoni, Kyle Gowen, et al.. (2015). Identification ofBRAFKinase Domain Duplications Across Multiple Tumor Types and Response to RAF Inhibitor Therapy. JAMA Oncology. 2(2). 272–272. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact